Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (491-500 of 706) with videos related to

Pageof 71
Sort By:
Early Intervention in Psychiatry|November 19, 2016
Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?Lisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Current Hypertension Reports|March 29, 2017
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Hamish Cg Prosser, Cynthia Gregory, Dagmara Hering, et al.
Expert Review of Cardiovascular Therapy|August 28, 2015
Challenges in the care of familial hypercholesterolemia: a community care perspectiveTom Brett, Gerald F Watts, Diane E Arnold-Reed, et al.
European Journal of Clinical Investigation|July 6, 2016
Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-IIIEsther M Ooi, Dick C Chan, Leanne Hodson, et al.
International Journal of Cardiology|September 5, 2015
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Journal of the American Heart Association|September 15, 2016
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II StudyErik Stroes, John R Guyton, Norman Lepor, et al.
Schizophrenia Research|September 27, 2016
The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosisLisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Co-Design of Strategies to Support the Implementation of a Paediatric Risk-Reduction Pathway for Familial HypercholesterolaemiaMitchell Sarkies, Shubha Srinivasan, Ari Horton, et al.
Atherosclerosis|December 10, 2021
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian populationWann Jia Loh, Xuling Chang, Tar Choon Aw, et al.
Atherosclerosis|August 3, 2015
Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudyJason A Harmer, Anthony C Keech, Anne-Sophie Veillard, et al.
Pageof 71

Showing results (491-500 of 706) with videos related to

Sort By:
Pageof 71
Early Intervention in Psychiatry|November 19, 2016
Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?Lisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Current Hypertension Reports|March 29, 2017
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Hamish Cg Prosser, Cynthia Gregory, Dagmara Hering, et al.
Expert Review of Cardiovascular Therapy|August 28, 2015
Challenges in the care of familial hypercholesterolemia: a community care perspectiveTom Brett, Gerald F Watts, Diane E Arnold-Reed, et al.
European Journal of Clinical Investigation|July 6, 2016
Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-IIIEsther M Ooi, Dick C Chan, Leanne Hodson, et al.
International Journal of Cardiology|September 5, 2015
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Journal of the American Heart Association|September 15, 2016
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II StudyErik Stroes, John R Guyton, Norman Lepor, et al.
Schizophrenia Research|September 27, 2016
The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosisLisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Co-Design of Strategies to Support the Implementation of a Paediatric Risk-Reduction Pathway for Familial HypercholesterolaemiaMitchell Sarkies, Shubha Srinivasan, Ari Horton, et al.
Atherosclerosis|December 10, 2021
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian populationWann Jia Loh, Xuling Chang, Tar Choon Aw, et al.
Atherosclerosis|August 3, 2015
Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudyJason A Harmer, Anthony C Keech, Anne-Sophie Veillard, et al.
Pageof 71